A COMPARISON OF THE EFFICACY OF CETIRIZINE AND TERFENADINE - A DOUBLE-BLIND, CONTROLLED-STUDY OF CHRONIC IDIOPATHIC URTICARIA

被引:21
作者
ANDRI, L [1 ]
SENNA, GE [1 ]
BETTELI, C [1 ]
GIVANNI, S [1 ]
ANDRI, G [1 ]
LOMBARDI, C [1 ]
MEZZELANI, P [1 ]
机构
[1] UNIV VERONA, IST CLIN MED, I-37100 VERONA, ITALY
关键词
ANTIHISTAMINES; CETIRIZINE; TERFENADINE; URTICARIA;
D O I
10.1111/j.1398-9995.1993.tb02406.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
In a 20-d, double-blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria. Subjects were randomly divided into two 15-patient groups. The first group was given cetirizine (10 mg once daily); the second terfenadine (60 mg twice daily). Cetirizine proved to be more effective than terfenadine in controlling urticaria symptoms. In fact, the score of the investigators' overall assessment was significantly lower in the cetirizine-treated group than in the terfenadine-treated group. Moreover, patient evaluation by a visual analog scale and symptoms assessed on a 4-point scale showed a better improvement in the cetirizine group. The number and severity of side-effects were similar in both treatment groups.
引用
收藏
页码:358 / 365
页数:8
相关论文
共 50 条
  • [41] Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
    Maurer, Marcus
    Casale, Thomas B.
    Saini, Sarbjit S.
    Ben-Shoshan, Moshe
    Gimenez-Arnau, Ana M.
    Bernstein, Jonathan A.
    Yagami, Akiko
    Stjepanovic, Aleksandra
    Radin, Allen
    Staudinger, Heribert W.
    Patel, Naimish
    Amin, Nikhil
    Akinlade, Bolanle
    Fan, Chunpeng
    Bauer, Deborah
    Yancopoulos, George D.
    Patel, Kiran
    Mannent, Leda P.
    Laws, Elizabeth
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (01) : 184 - 194
  • [42] Morning and evening efficacy evaluation of rupatadine ( 10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
    Marmouz, Farid
    Giralt, Josep
    Izquierdo, Inaki
    JOURNAL OF ASTHMA AND ALLERGY, 2011, 4 : 27 - 35
  • [43] Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial:: First results of ETAC®
    Warner, JO
    Businco, L
    Casimir, G
    Diepgen, TL
    Kjellman, M
    Knol, K
    Menardo, JL
    Naspitz, C
    Wahn, U
    Agboton, C
    de Longueville, M
    de Patoul, MC
    Meredith, S
    Vandepaer, M
    Albertini, M
    Bourrier, T
    Bauer, CP
    Franz, R
    Bellon, G
    Bodart, E
    Boner, A
    Fortunati, P
    Botey, J
    Marin, AM
    Cavagni, G
    Gardenghi, M
    Clifford, R
    Griffith, H
    Darras, JP
    de Benedictis, H
    Pazzelli, P
    De Raeve, LE
    Kempinaire, A
    Dutau, G
    Rance, F
    Eichler, I
    Rath, R
    Fauquert, JL
    Piollet, A
    Foote, KD
    Griffioen, RW
    Smitt, JHS
    van Nierop, JC
    Grimfeld, A
    Sahraoui, F
    Guillet, MH
    Guillet, G
    Gustafsson, D
    Ekholm, L
    Hamel-Teillac, D
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 1998, 9 (03) : 116 - 124
  • [44] Comparison of on-site and photographic evaluations of the suppressive effects of cetirizine, loratadine, and fexofenadine on skin response to histamine iontophoresis: A double-blind, crossover study in healthy volunteers
    Tsuda, H
    Takiwaki, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (04): : 307 - 322
  • [45] Comparison of efficacy and safety of second-generation H1-antihisatamines in therapy of chronic idiopathic urticaria
    Kowal, Krzysztof
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2014, 1 (02) : 65 - 69
  • [46] A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
    Anne K Ellis
    Yifei Zhu
    Lisa M Steacy
    Terry Walker
    James H Day
    Allergy, Asthma & Clinical Immunology, 9
  • [47] Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study
    Nielsen, PN
    Skov, PS
    Poulsen, LK
    Schmelz, M
    Petersen, LJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (09) : 1378 - 1384
  • [48] Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: a placebo-controlled, parallel-group, dose-ranging study
    Paul, E
    Berth-Jones, J
    Ortonne, JP
    Stern, M
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1998, 9 (03) : 143 - 149
  • [49] DOUBLE-BLIND COMPARISON BETWEEN TERFENADINE (120MG/DAY) AND LORATADINE (10MG/DAY) IN PATIENTS WITH SEASONAL ALLERGIC RHINITIS
    FUCHS, T
    ULRICH, R
    BUTT, U
    ALLERGOLOGIE, 1992, 15 (10) : 336 - 340
  • [50] Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study
    Potter, Paul
    Maspero, Jorge F.
    Vermeulen, Jan
    Barkai, Laszlo
    Nemeth, Ildiko
    Baillieau, Rene A.
    Garde, Jesus M.
    Giralt, Josep
    Domenech, Alejandro
    Izquierdo, Inaki
    Nieto, Antonio
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2013, 24 (02) : 144 - 150